First full quarter with Calavo in the P&L, and the synergy target already moved up — while the avocado price recovery quietly did the rest.
AVO · Earnings Call · 2026-09-08
The first real look at the combined company
Mission Produce's fiscal Q3 was the first reporting period that stacked Calavo inside the P&L, and it showed what the deal was bought for. Revenue reached $450 million, up 26% year over year, on avocado volume that rose 38%. CEO John Pawlowski called it “an extremely important quarter for Mission. It was our first reporting period following the completion of the acquisition, and it provided an early look at the capabilities of the combined organization.” — John Pawlowski, President and Chief Executive Officer · 2026-09-08 The scale jump is dramatic against the last hard filing: total revenue was $291 million in the 10-Q filed before the deal closed. And it lands at an inflection — U.S. retail avocado volume grew ~9% y/y even as prices rose ~15% sequentially, which management frames as evidence the low-price period expanded the avocado category rather than merely discounting it.
A synergy target that moved up, not down
The genuinely company-unique signal this quarter is the number that moved: annualized cost synergies went from "at least $25 million" to more than $30 million, attributed by management to higher SG&A savings and network efficiencies found only once the two teams shared a roof. On the call, Mark Smith pressed for the delta.
It really came down to the fact that the two organizations over the first five to eight weeks of working together started to really kind of put rubber to the road... finding incremental transportation synergies, finding opportunities that the way we were co-operating our facilities in our Mexican packhouses... just things that we weren't really able to get into the proverbial weeds on when we were doing due diligence.
That is a classic post-merger tell — due-diligence assumptions being beaten from the inside. It also reverses the usual M&A script, where integration costs page in and synergy targets quietly get trimmed; here the guidance moved the other way. Pawlowski also framed the customer math bluntly: “X market share plus B market share should equal C plus market share in the future” — John Pawlowski, President and Chief Executive Officer · 2026-09-08 — the intent is to take share, not just stack two books.
The margin trade-off beneath the beat
Adjusted EBITDA of $32.4 million beat the high end of the $28–32 million range, but the mix was uneven. Gross margin compressed 270bps to 9.9% as average per-unit avocado prices fell 9%. International Farming segment EBITDA was $7.6 million versus $12.1 million a year ago, dragged by lower pricing on owned Peruvian fruit. CFO Bryan Giles set up Q4: “a lot of our lower-yielding farms... the fruit that sold through in our Q3 tended to be higher-cost-basis fruit... whereas Q4 we're leaning more heavily into our higher-yielding farms this year.” — Bryan Giles, Chief Financial Officer · 2026-09-08 The margin profile of the combined company is still levered to per-unit avocado margin, not to the headline synergy number — a useful reality check for anyone extrapolating the $30 million straight to the bottom line.
What quietly fell off the tape: tariffs
The contrast with prior quarters is striking. A year ago the tariff question dominated Mission's Q&A, with management guiding to roughly “$10 million impact” — Benjamin Klieve · 2025-09-08 for the fiscal year and spending minutes on border skittishness. This quarter, tariffs appear nowhere in Mission's keyword set — the interrogation has rotated entirely to integration and synergy execution. The recurring risk that did survive is El Niño. Back in June, John warned: “We do think there could be an impact on 2027, but we feel like we are in a spot where we can plan for that.” — John Pawlowski, President and Chief Executive Officer · 2026-06-08 He confirmed this quarter that the Peruvian crop came in at a record 120–130 million pounds despite those conditions.
What the fundamentals and the tape say
The last filed balance sheet still reflects the pre-Calavo company, and it was already stretched. effective net cash sat at -$85 million before the deal added roughly $400 million of long-term debt; interest expense jumped to $5.1 million from $2.4 million. interest coverage was already negative at -4.6x, and free cash flow was -$30 million on seasonal working-capital building. Management's stated capital-allocation order — integration, liquidity, debt reduction, selective growth, buybacks — is exactly what that balance sheet demands. The stock hasn't voted yet. AVO's price-to-revenue sits at 0.8x, up about 41% y/y, but the shares are roughly flat over the last 90 days. With the Investor Day set for October and Q4 guided to $52–55 million of EBITDA — a full quarter of Calavo plus the seasonal Peru and blueberry ramp — the market is waiting for proof that the synergy math converts to cash before re-rating further.